ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Mental Health
Serum Progesterone and Testosterone Levels in Schizophrenia Patients at Different Stages of Treatment
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 226242" data-attributes="member: 3"><p><strong>Testosterone for schizophrenia</strong></p><p>Elias, Alby ; Kumar, Ajit ; Elias, Alby</p><p>Cochrane database of systematic reviews, 2007-07-18, Vol.2012 (2), p.CD006197-CD006197</p><p></p><p>Background: Recently, sex hormones such as estrogens and testosterone or its derivatives have been the focus of interest for treatment of persistent symptoms associated with schizophrenia. Objectives To review the effects of dehydroepiandrosterone (DHEA)/testosterone as adjunctive therapy to standard antipsychotic drugs. Search methods We searched the Cochrane Schizophrenia Group Trials Register (January 2007). Selection criteria <strong>We included all clinical randomised trials comparing DHEA/testosterone plus standard antipsychotic treatment with standard treatment alone.</strong> Data collection and analysis We independently selected studies and extracted data. For dichotomous data we calculated the relative risk (RR) and its 95% confidence interval (CI) on an intention to treat basis, using a fixed effects model. We presented continuous data using the weighted mean difference statistic, with a 95% confidence interval using a fixed effects model. Main results We found three relevant small, short trials (total n=126). Clinical Global Impression data were equivocal (n=27, 1 RCT, WMD ‐0.43 CI ‐0.9 to 0.1). <strong>Average total PANSS scores were not significantly different between the DHEA plus antipsychotic group and those given antipsychotic drugs and placebo </strong>(n=82, 2 RCTs, WMD ‐4.16 CI ‐13.8 to 5.5). PANSS positive scores were equivocal (n=55, 1 RCT, WMD ‐1.00 CI ‐3.8 to 1.8).<strong> For negative symptoms binary SANS scale data favoured the DHEA plus antipsychotic group</strong> (n=30, 1 RCT, RR 0.23 CI 0.1 to 0.6, NNT 2 CI 2 to 3) but PANSS negative scores were not significantly different between comparison groups (n=55, 1 RCT, WMD ‐2.30 CI ‐6.4 to 1.8). About 17% of people left both groups early (n=64, 2 RCTs, RR 0.80 CI 0.3 to 2.4). St Hans Rating Scale data for extrapyramidal symptoms favoured the DHEA plus antipsychotic group (n=30, 1 RCT, WMD ‐5.00 CI ‐8.8 to ‐1.2) but akathisia ratings were equivocal (n=34, 1 RCT, RR 2.67 CI 0.3 to 23.1). Ratings of parkinsonian movement disorder differed within the same trial depending of the outcome scale used. <strong>Quality of life seemed unaffected by use of DHEA </strong>(n=55, 1 RCT, WMD 6.20 CI ‐1.4 to 13.8). Authors' conclusions Results are inconclusive with most outcomes being either non‐significant or producing contradictory findings. Currently, adjunctive DHEA should remain an experimental treatment for people with schizophrenia.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 226242, member: 3"] [B]Testosterone for schizophrenia[/B] Elias, Alby ; Kumar, Ajit ; Elias, Alby Cochrane database of systematic reviews, 2007-07-18, Vol.2012 (2), p.CD006197-CD006197 Background: Recently, sex hormones such as estrogens and testosterone or its derivatives have been the focus of interest for treatment of persistent symptoms associated with schizophrenia. Objectives To review the effects of dehydroepiandrosterone (DHEA)/testosterone as adjunctive therapy to standard antipsychotic drugs. Search methods We searched the Cochrane Schizophrenia Group Trials Register (January 2007). Selection criteria [B]We included all clinical randomised trials comparing DHEA/testosterone plus standard antipsychotic treatment with standard treatment alone.[/B] Data collection and analysis We independently selected studies and extracted data. For dichotomous data we calculated the relative risk (RR) and its 95% confidence interval (CI) on an intention to treat basis, using a fixed effects model. We presented continuous data using the weighted mean difference statistic, with a 95% confidence interval using a fixed effects model. Main results We found three relevant small, short trials (total n=126). Clinical Global Impression data were equivocal (n=27, 1 RCT, WMD ‐0.43 CI ‐0.9 to 0.1). [B]Average total PANSS scores were not significantly different between the DHEA plus antipsychotic group and those given antipsychotic drugs and placebo [/B](n=82, 2 RCTs, WMD ‐4.16 CI ‐13.8 to 5.5). PANSS positive scores were equivocal (n=55, 1 RCT, WMD ‐1.00 CI ‐3.8 to 1.8).[B] For negative symptoms binary SANS scale data favoured the DHEA plus antipsychotic group[/B] (n=30, 1 RCT, RR 0.23 CI 0.1 to 0.6, NNT 2 CI 2 to 3) but PANSS negative scores were not significantly different between comparison groups (n=55, 1 RCT, WMD ‐2.30 CI ‐6.4 to 1.8). About 17% of people left both groups early (n=64, 2 RCTs, RR 0.80 CI 0.3 to 2.4). St Hans Rating Scale data for extrapyramidal symptoms favoured the DHEA plus antipsychotic group (n=30, 1 RCT, WMD ‐5.00 CI ‐8.8 to ‐1.2) but akathisia ratings were equivocal (n=34, 1 RCT, RR 2.67 CI 0.3 to 23.1). Ratings of parkinsonian movement disorder differed within the same trial depending of the outcome scale used. [B]Quality of life seemed unaffected by use of DHEA [/B](n=55, 1 RCT, WMD 6.20 CI ‐1.4 to 13.8). Authors' conclusions Results are inconclusive with most outcomes being either non‐significant or producing contradictory findings. Currently, adjunctive DHEA should remain an experimental treatment for people with schizophrenia. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Mental Health
Serum Progesterone and Testosterone Levels in Schizophrenia Patients at Different Stages of Treatment
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top